Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.30 | N/A |
| PEG Ratio (TTM) | 4.15 | N/A |
| P/S Ratio (TTM) | 0.63 | N/A |
| P/B Ratio (TTM) | 1.36 | N/A |
| P/FCF Ratio (TTM) | 10.23 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 6.24% | N/A |
| ROE (TTM) | 9.85% | N/A |
| Net Profit Margin (TTM) | 4.44% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 13.02% | 71.43% | N/A |
| Revenue | -6.71% | 123.92% | N/A |
| Net Income | 12.39% | 112.14% | N/A |
| Cash Flow | 109.84% | 563.06% | N/A |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.19 | N/A |
| Quick Ratio (TTM) | 2.19 | N/A |
| D/E Ratio (TTM) | 0.09 | N/A |
| Interest Coverage (TTM) | 0.01 | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | 50.37 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |